Carregant...
Phospho-aspirin (MDC-22) prevents pancreatic carcinogenesis in mice
Pancreatic cancer (PC) is a deadly disease with a dismal 5-year survival rate of <6%. The currently limited treatment options for PC underscore the need for novel chemopreventive and therapeutic agents. Accumulating evidence indicates that aspirin use is associated with a decreased risk of PC. Ho...
Guardat en:
| Publicat a: | Cancer Prev Res (Phila) |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930743/ https://ncbi.nlm.nih.gov/pubmed/27138793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-15-0344 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|